Small cell carcinoma of lungs
Small cell carcinoma of lungs
Updated: 10/15/2020
© Jun Wang, MD, PhD
General features
- Also called oat cell carcinoma
- Poorly differentiated neuroendocrine tumor
- Derived from primitive cells of basal bronchial epithelium
- More common in men, median age 60
- Strong association with tobacco smoking
- Most common lung cancer associated with uranium mining, probably associated with radon
- Smoking cessation associated with improved survival
Key clinical features
- Nonspecific presentations similar to other lung cancer: cough, dyspnea, etc
- Associated paraneoplastic syndromes due to production of ACTH, ADH, calcitonin, etc
- Lambert-Eaton myasthenic syndrome
Presynaptic disorder of neuromuscular
transmission
Autoimmune
process against voltage-gated
calcium channels (VGCCs)
Occasionally antibodies against acetylcholine receptor, but usually low
titers (High titer seen in myasthenia gravis)
Impaired release of acetylcholine
Presentations: Proximal muscle weakness, depressed tendon reflexes, posttetanic
potentiation, and autonomic changes
- Acanthosis nigricans: Brown, velvety and verrucous plaques in axillae, back of neck and other skin folds, associated with visceral malignancies, endocrine diseases and congenital disorders
- Leukemoidreactions: Reactive leukocytosis due to tumor produced bioactive factors
- Trousseau syndrome: Acquired blood clotting disorder that results in migratory thrombophlebitis, commonly associated with internal malignancy, probably due to cancer caused imbalance of coagulative system
- Hypertrophic pulmonary osteoarthropathy: Syndrome of clubbing of the digits, periostitis of the long (tubular) bones, and arthritis, probably associated with tumor released cytokine, growth factor, etc
Key morphological features
- Mass, usually central/hilar located
- Sheets and nests of small to intermediate sized cells with scant cytoplasm
- Molding nuclei with salt and pepper chromatin pattern
Markers
- Positive: Cytokeratin, TTF1
- Positive for neuroendocrine markers: CD56, neuron specific enolase, chromogranin, synaptophysin
- Negative: CD45 and other lymphocytic markers
Treatment
- Chemotherapy
- Radiation therapy
Indicators for poor prognosis
- Elevated serum LDH/alkaline phosphatase
- Relapsed disease
- Weight loss of greater than 10% of baseline body weight
- Poor performance status
- Hyponatremia
Back to respiratory tract neoplasms
Back to contents
Comments
Post a Comment